NCT02447029View on ClinicalTrials.gov

Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Pregnancy, Unwanted
Interventions
DRUG

vaginal 2% Xylocaine

patient-administered vaginal lidocaine jelly versus provider-administered standard lidocaine paracervical block

DRUG

standard lidocaine paracervical block

1% lidocaine paracervical injection

Trial Locations (1)

Unknown

Planned Parenthood Mar Monte, San Jose

All Listed Sponsors
lead

Stanford University

OTHER

NCT02447029 - Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter